1 year return (CAGR)
-60.08%
Kalaris Therapeutics, Inc. Exchange (NASDAQ, USD)
KLRS
2.83
+0.13 (+4.81%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
67.37M
Price/Sales
-
Ent value
66.06M
Price/Book
1.17
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-45.59%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.72 |
| Daily high | 2.85 |
| Daily low | 2.58 |
| Daily Volume | 27K |
| All-time high | 10.98 |
| 1y analyst estimate | 18.71 |
| Beta | - |
| EPS (TTM) | -1.86 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KLRS | S&P500 | |
| Current price drop from All-time high | -74.23% | -0.39% |
| Highest price drop | -75.41% | -56.47% |
| Date of highest drop | 2 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -39.38% | -10.67% |
| Avg time to new high | 22 days | 12 days |
| Max time to new high | 158 days | 1805 days |
News
